Alpha-GPC vs CDP-Choline

Mechanism — same endpoint, different pathways

Both compounds end up raising brain acetylcholine, but they get there differently. Alpha-GPC (L-alpha-glycerylphosphorylcholine) splits into choline + glycerophosphate in the gut; the choline crosses the blood-brain barrier and gets esterified into acetylcholine by ChAT. CDP-choline (cytidine 5'-diphosphocholine, also called citicoline) hydrolyzes in the gut into cytidine + choline; the cytidine converts to uridine (a separate pyrimidine pathway involved in membrane phospholipid synthesis + dopamine signaling) while the choline takes the same route to acetylcholine. The practical implication: alpha-GPC is a higher-yield choline donor per gram; CDP-choline adds the cytidine/uridine arm which has independent cognitive effects.

• Alpha-GPC: 40% choline by weight; crosses BBB directly; fast onset (~30-60 min peak)
• CDP-choline: 18% choline by weight; also delivers cytidine → uridine → membrane phospholipid synthesis
• Why both work: Both raise brain acetylcholine — same downstream effect on focus + memory

Evidence — what trials measured

Alpha-GPC has stronger acute performance data. Bellar et al. (2015 J Int Soc Sports Nutr) showed 600 mg alpha-GPC 45 min pre-workout raised peak bench-press force 14% in trained adults. Ziegenfuss et al. (2008) showed similar power-output gains. Cognitively, De Jesus Moreno (2003) showed 1200 mg/day alpha-GPC improved scores on the ADAS-Cog scale in mild-to-moderate Alzheimer's patients over 6 months. CDP-choline has stronger chronic cognitive support data. McGlade et al. (2012 Food Nutr Sci) showed 250-500 mg/day citicoline over 28 days improved attention + psychomotor speed in healthy adolescent females. Multiple trials in stroke recovery + age-related cognitive decline show CDP-choline benefit at 500-1000 mg/day. Bottom line: alpha-GPC for acute boosts, CDP-choline for sustained cognitive support.

• Alpha-GPC — Bellar 2015: 600 mg pre-workout: 14% peak bench-press force gain in trained adults
• Alpha-GPC — De Jesus 2003: 1200 mg/day, 6 mos: improved ADAS-Cog scores in Alzheimer's
• CDP-choline — McGlade 2012: 250-500 mg/day, 28 days: improved attention + processing speed in adolescents
• CDP-choline — stroke trials: 500-1000 mg/day: improvements in post-stroke recovery + age-related decline

Dosing — when to take + how much

Alpha-GPC typical dose: 300-600 mg taken 30-60 min before a cognitive or athletic demand. Half-life is short (~3-4 hours), peak effect ~45 min post-dose. Can be split into 300 mg morning + 300 mg early afternoon for sustained-cognitive use, but most users hit it just before training or focused work. CDP-choline (citicoline) typical dose: 250-500 mg/day, often split AM + PM. Half-life is longer (~14-18 hours) so daily steady-state dosing matters more than acute timing. Combined dose for chronic use: 300 mg alpha-GPC morning + 250-500 mg CDP-choline morning is a common nootropic stack — covers acute + chronic choline support without redundancy.

• Alpha-GPC: 300-600 mg, 30-60 min pre-task; short half-life ~3-4 hrs
• CDP-choline: 250-500 mg/day, often split AM + PM; long half-life ~14-18 hrs
• Combined stack: Alpha-GPC 300 mg + CDP-choline 250-500 mg = acute + chronic coverage

Safety — both very clean

Both compounds have excellent safety profiles in published trials. Alpha-GPC: main side effect is headache in some users at >600 mg/day (typically resolves within 1-2 weeks). Long-term observational data raised a question about CV risk via TMAO metabolites (Bell et al. 2017), but the signal was modest + has not been replicated in subsequent trials. CDP-choline: essentially side-effect free at typical doses. Rare GI upset or mild headache at >1 g/day. No serious adverse events reported in multi-year trials at 500-1000 mg/day. Neither compound has significant drug interactions. Anticholinergic medications (some antihistamines, tricyclic antidepressants) may blunt the cognitive effects, but no harm. Both are well-tolerated in stack protocols with racetams (piracetam, oxiracetam) — common nootropic combos rely on supplemental choline to prevent the racetam-induced headache that comes from acetylcholine depletion.

• Alpha-GPC: Headache in some users >600 mg/day; modest unreplicated TMAO/CV question (Bell 2017)
• CDP-choline: Very clean profile; rare GI/headache at >1 g/day; no serious adverse events
• Stack with racetams: Both prevent the acetylcholine-depletion headache from piracetam, oxiracetam, etc.

Cost — both affordable

Alpha-GPC: quality brands (Double Wood, Nootropics Depot, Pure Encapsulations) run $20-40/month at 300-600 mg/day. Bulk powder from reputable suppliers is cheaper at $0.30-0.60/g but most users prefer capsules for dose precision. CDP-choline (citicoline): Cognizin is the patented form licensed across Jarrow, Doctor's Best, and others; runs $25-50/month at 250-500 mg/day. Generic citicoline is somewhat cheaper. The combined stack (300 mg alpha-GPC + 250 mg CDP-choline daily) runs $40-80/month at retail. Both are essentially the same cost-per-effect zone — choose based on use case, not price.

• Alpha-GPC: Quality brands $20-40/mo at 300-600 mg/day
• CDP-choline (Cognizin): Quality brands $25-50/mo at 250-500 mg/day
• Stack cost: Combined alpha-GPC + CDP-choline: $40-80/mo

Who chooses which

For pre-workout cognitive + power boost: alpha-GPC wins. Faster onset, stronger acute power-output data, well-validated in trained-adult trials. Standard pre-training stack: 300-600 mg alpha-GPC + 200 mg caffeine + 200 mg L-theanine 30-60 min before training. For chronic cognitive support + age-related cognitive maintenance: CDP-choline wins. The cytidine/uridine arm adds membrane phospholipid support that alpha-GPC alone doesn't provide. For stacking with racetams (piracetam, aniracetam, oxiracetam): either works as a choline source. Most experienced nootropic users default to alpha-GPC for racetam pairing because of the faster onset matching the racetam's onset. For a complete cognitive stack covering acute + chronic: use both at lower doses (300 mg + 250 mg) rather than maxing out either one.